As a way to capitalize on the booming US cannabis market, the managers for one of Canada’s top marijuana-focused exchange-traded funds (ETFs) say they want an ETF for US companies only.

On Thursday (March 21), Steve Hawkins, president and CEO of Horizons ETFs Management, told BNN Bloomberg his company is “actively pursuing” a new fund with only US-based marijuana firms.

As part of the most recent quarterly rebalancing for the Horizons Marijuana Life Sciences Index ETF (HMMJ) (TSX:HMMJ), which included the addition of 10 new stocks to the fund, Colorado-based Charlotte’s Web Holdings (CSE:CWEB,OTCQX:CWBHF) joined the ETF.

The company is only focused on the hemp industry, including the development of hemp-derived cannabidiol (CBD). Hemp operations were legalized in the US thanks to the passing of a farm bill in December 2018.

“Charlotte’s Web does not produce or sell medicinal or recreational marijuana or products derived therefrom,” the company’s listing profile on the Canadian Securities Exchange (CSE) indicates.

The ETF operators signaled to investors that the addition of Charlotte’s Web was a “major” move for the fund, as Horizons ETFs is seeking to pursue the current boom for the hemp-derived US CBD market.

“This is another exciting growth market through which HMMJ can provide exposure, given the regulatory changes in the United States,” Hawkins said in a press release.

Up to this point, the HMMJ operators have remained diligent with guidance from exchange regulators at TMX Group — meaning HMMJ has not held any US-based marijuana companies due to the continued federal illegality of the plant in the US.

Now HMMJ is officially signaling to investors that it will pursue a way to create an ETF with the US market in mind, including the latest investment trend in the marijuana space: multi-state operators (MSOs).

These MSOs operate cannabis assets across legal US markets such as growing facilities, networks of dispensaries and lines of branded products for medical and recreational uses.

Fellow funds already seeking US plays

Through a variety of other funds, cannabis investors have already been able to see the impact MSOs and other US ventures have had on the returns available.

In February, Purpose Investments announced that its Purpose Marijuana Opportunities Fund (NEO:MJJ) had secured investors a return of 53.43 percent on a one-year basis since its inception on January 31, 2018.

Greg Taylor, chief investment officer of Purpose Investments and portfolio manager of the fund, credited the results to the fund’s ability to seek “thematic opportunities, such as the rapid product innovation happening now in the US.”

Currently, the holdings of Purpose Investments’ marijuana fund are 61.55 percent from Canada and 21.11 percent from the US.

MSOs such as Green Thumb Industries (CSE:GTII,OTCQX:GTBIF), Curaleaf Holdings (CSE:CURA,OTCQX:CURLF), Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF) and Green Growth Brands (CSE:GGB,OTCQB:GGBXF) appear among the fund’s top holdings.

Additionally, Charlotte’s Web is listed as a top holding in weight for the overall fund.

“What we’ve done is become more aggressive on the US cannabis names, just over the past five to six months, rather than focus on the Canadian licensed producers,” Nawan Butt, portfolio manager with Purpose Investments, previously told the Investing News Network.

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Green Growth Brands is a client of the Investing News Network. This article is not paid-for content.

 BioHarvest Sciences Inc. (CSE: BHSC) (the “Company” or “BioHarvest”) invites its shareholders and the general public to join a Live Video Conference (“Webinar”) on Thursday, January 21st, 2021 at 2:00 PM Eastern Standard Time (11:00 AM Pacific Standard Time). Ilan Sobel, CEO of BHSC, will host the event and discuss progress on Bioharvest’s Growth Plan, which will include highlights of the 2020 milestones achieved, key business capabilities built, and will provide an important overview of 2021 Priorities.

The presentation will be approximately 35 minutes, followed by a live question and answer session.

Keep reading... Show less

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”), reports that it has sold its 50% interest in Cobra Ventures Inc. (“Cobra”), which sale included all funds previously advanced by World Class to Cobra, to the remaining shareholder of Cobra, for $2,500,000 in cash

An investment group led by Richard Goldstein retains 100% control of Cobra, and its senior secured debenture of Hydrx Farms Ltd. (“Hydrx”), acquired by Cobra in October 2020.

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Kurt Schmidt, President and Chief Executive Officer, will speak at the 24th Annual CIBC Western Institutional Investor Conference on Friday, January 22, 2021 at 4:10 p.m. EST.

A recording will be available on the Investors section of the Company’s website at .

Keep reading... Show less
  • Disease control of root-rot Aphanomyces zoospores in laboratory tests.
  • Outstanding Efficacy: 100% control at economic application rates within 24 hours.
  • Aphanomyces is a soil-borne root-rot disease that destroys peas, lentils, and legume crops.

MustGrow Biologics Corp. (CSE: MGRO) (OTC: MGROF) (FSE: 0C0) (the “Company”, “MustGrow”) is pleased to announce successful laboratory test results of its patented mustard-derived biopesticide on Aphanomyces euteiches zoospores (“Aphanomyces”) via an independent third party facility: 100% control at economic application rates within 24 hours. MustGrow will now advance to larger scale greenhouse and field tests. Study results and applicability are patent-protected under MustGrow’s existing suite of issued patents.

MustGrow’s remarkably safe and effective organic biopesticide is plant-based – harnessing the mustard seed’s natural defense mechanism to control diseases, pests, and weeds with an organic food-grade biopesticide.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced the hiring of CPG industry veteran Ty Gent as the Company’s new Chief Operating Officer (“COO”). As COO, Gent will be responsible for operational consistency and efficiency across markets and implementation of structural enhancements to facilitate scaling.

This press release features multimedia. View the full release here:

Keep reading... Show less